Diseases [C] » Musculoskeletal Diseases [C05] » Bone Diseases » Bone Diseases, Metabolic » Osteoporosis
Diseases [C] » Nutritional and Metabolic Diseases [C18] » Metabolic Diseases » Bone Diseases, Metabolic » Osteoporosis
Description
Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. MeSH
Hierarchy View
Subtype Terms (1)
Osteoporosis, Postmenopausal
67 drugs (29 approved, 38 experimental)
Approved Indicated Drugs (17)
Phase 4 Indicated Drugs (49)
Phase 3 Indicated Drugs (36)
Phase 2 Indicated Drugs (38)
Phase 1 Indicated Drugs (26)
Other Experimental Indicated Drugs (36)
Organization Involved with Phase 4 Indications (109)
Alliance for Better Bone Health
Badalona Hospital Germans Trias i Pujol
Chinese University of Hong Kong
CIHR Canadian HIV Trials Network
Crozer Chester Medical Center, Pennsylvania
Holdsworth House Medical Practice
Institut Hospital del Mar d'Investigacions Mèdiques
Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
Kessler Institute for Rehabilitation
National Institute of Mental Health (NIMH)
National Institute on Aging (NIA)
National Institutes of Health (NIH)
Osteoporosis Center of Delaware County
Spokane Joint Replacement Center
Taichung Veterans General Hospital
The University of Texas, Dallas
United States Department of Agriculture
University Hospital of North Norway
Organization Involved with Phase 3 Indications (115)
Alberta Heritage Foundation for Medical Research
Alfried Krupp Krankenhaus Essen Steele
Apollo Hospitals, Chennai, India
Assistance Publique - Hôpitaux de Paris
Bethesda Health Research Center
Canadian Institutes of Health Research (CIHR)
Canadian Urology Research Consortium
Chinese Academy of Medical Sciences
Dutch Health Care Insurance Board
Elizabeth Glaser Pediatric AIDS Foundation
Evangelisches Krankenhaus Lutherhaus gGmbH
French National Agency for Research on AIDS and Viral Hepatitis
German Federal Ministry of Education and Research
Glaser Pediatric Research Network
Heart and Stroke Foundation of Canada
Herbert Irving Comprehensive Cancer Center
International Breast Cancer Study Group
Medwin Hospital, Hyderabad, AP, India
National Center for Complementary and Integrative Health (NCCIH)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute for Health Research, United Kingdom
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
North Central Cancer Treatment Group
Office of Dietary Supplements (ODS)
Oncocare Sonnenhof-Klinik Engeriedspital
Ontario Neurotrauma Foundation
P.D. Hinduja Hospital and Medical Research Centre, Mumbai
Queen Elizabeth Hospital NHS Foundation Trust
Radiation Therapy Oncology Group
Organization Involved with Phase 2 Indications (60)
Fujian Academy of Traditional Chinese Medicine
Korea Health Industry Development Institute
Laikο General Hospital, Athens
Medical University of South Carolina
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Neurological Disorders and Stroke (NINDS)
Osteoporosis Center of Armenia
Shenzhen Salubris Pharmaceuticals Co., Ltd.
State University of New York, Buffalo
Taipei Veteran General hospital
Organization Involved with Phase 1 Indications (45)
Autonomous University of Madrid
California Institute for Regenerative Medicine
Centre de Recherche en Nutrition Humaine d'Ile-de-France
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Organization Involved with Other Experimental Indications (72)
European Regional Development Fund
Fuzhou Infectious Diseases Hospital
Guangxi Autonomous Region Longtan Hospital
Integrative Health Technologies
National Institute of Nutrition and Seafood Research, Norway
North Carolina Agricultural and Technical State University
Oregon Health and Science University
Postgraduate Institute of Medical Education and Research
Pure North S'Energy Foundation
Shenzhen Third People's Hospital
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
